Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Synthetic peptide fragment, prion protein analo...
Endogenous cardiomodulatory peptide; NPR-A agon...
Hydroxycinnamic acid found in various plant sou...
Steroid hormone, contraceptive; PR agonist.
GSK-3β inhibitor.
Pt-based DNA cross-linker.
Aspirin analog; hemoglobin chain cross-linker.<...
Electron carrier used to study dehydrogenase el...
Endogenous peptide hormone, involved in water h...
Endogenous amino acid, forms disulfide bridges ...
mTOR inhibitor.
Polymethoxylated flavone found in citrus fruits...
Triazole; 14-α demethylase and aromatase inhib...
PKC and S6 kinase substrate.
NSAID; COX inhibitor and HS-releasing agent.
σ2 agonist.
σ1 antagonist.
14-α demethylase inhibitor.
Peptide, derivative of AT II, involved in vasoc...
AurKB/C inhibitor.